Gynecologic Oncology | Novel Agents and Emerging Strategies in the Management of Gynecologic Cancers

published 4 months ago by Dr Neil Love

Faculty presentations from an independent satellite symposium during the Society of Gynecologic Oncology’s 2019 Annual Meeting on Women’s Cancer. Featuring perspectives from Dr Michael J Birrer, David M O’Malley, Matthew A Powell and Shannon N Westin: Biologic Rationale for and Current Research Database with Immune Checkpoint Inhibition in Gynecologic Cancers — Dr Powell (00:00) Targeting Folate Receptor Alpha (FRα) in Patients with Gynecologic Cancers — Dr Birrer (7:54) Other Novel Agents and Strategies Under Investigation for Cervical Cancer, Endometrial Cancer and Ovarian Cancer — Dr O’Malley (17:27) Ongoing Trials Examining the Role of Anti-PD-1/PD-L1 Antibodies in Combination with Chemotherapy, Targeted Agents or Other Immunotherapeutics — Dr Westin (27:50)  Select publications

more episodes from Research To Practice | Oncology Videos